Why I'm kicking myself I missed out on CSL shares

I'm still kicking myself on selling out of CSL Limited (ASX:CSL) shares. Here's why.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It was March 2015, my hair was long, summer was on the run and I was about to buy my first bunch of ASX shares. After doing some reading and research, I had narrowed my selection to 5 or 6 ASX shares that I considered worthy of my first investment dollars.

Among this list was biotech company CSL Limited (ASX: CSL). I was enamoured with the company's products, its already impressive stock price growth and its dominance in the medical space and so went ahead and purchased about 35 shares at around $94 (read it and weep).

The CSL story

CSL is a true innovator and its blood plasma production remains one of the best and most fortified earning streams amongst medical stocks on the ASX. CSL's work with researching and manufacturing influenza vaccines through its Seqirus division places it at the forefront of the fight against the flu (this year's deadly flu season is a tragic reminder of the importance of this work).

Fast forward about three years and CSL had been my standout stock performer. Most of the other (in hindsight, pretty poor) stock picks had either gone backwards or stayed depressingly static – but CSL had charged ahead. I watched the stock price climb to $120, then to $140. At $150 I had thoughts about 'cashing out' and 'taking the profit', because that what the pros do and I thought I was a bit of a genius for latching onto such a winner. Finally, I relented and sold out at $161, taking an 80% profit and feeling pretty good. The price-to-earnings (P/E) ratio for CSL was very high (sitting around 40 if I remember) and I thought that I had ridden the wave to its height and it was about to crash, and I may as well take the cash off the table.

Alas, I then had to endure watching CSL smash through the $200 mark, then $220 and finally $230. Although CSL has since pulled back, it still has a P/E ratio in the high 30s and I learnt my lesson…

Foolish takeaway

If you get a fantastic company on the cheap, never, ever sell unless you have to! Good companies give back by compounding your money in a continuous cycle and the longer you hold the shares, the richer you will become. I wish I could go back and not hit the sell button – I have spent the last two years waiting for a 'buy-the-dip' opportunity to get back in (that still hasn't materialised). But such is life…

Sebastian Bowen (sadly) has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A businessman compares the growth trajectory of property versus shares.
Growth Shares

The ASX stocks I think could define the next decade of growth

Analysts are recommending these growth machines to clients.

Read more »

a man in a green and gold Australian athletic kit roars ecstatically with a wide open mouth while his hands are clenched and raised as a shower of gold confetti falls in the sky around him.
Growth Shares

Top Australian stocks to buy right now with $2,000

There are good reasons why these shares are rated as buys by brokers.

Read more »

Piggybank with an army helmet and a drone next to it, symbolising a rising DroneShield share price.
Growth Shares

The sleeper defence stock set to explode? Up 240% in 2025, and poised to fire again!

A big part of the EOS story this year comes down to how quickly modern warfare is changing.

Read more »

a man sits on a ridge high above a large city full of high rise buildings as though he is thinking, contemplating the vista below.
Growth Shares

2 ASX shares to buy and hold for the next decade

I’m bullish about the long-term potential of these businesses…

Read more »

A woman crosses her hands in front of her body in a defensive stance indicating a trading halt.
Growth Shares

2 unstoppable ASX growth shares to buy and hold

These shares are positioned for strong growth over the next decade according to analysts.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Growth Shares

Here are the 3 Australian stocks I'd tell a new investor to buy asap

These shares could be top picks for new investors right now. Let's dig deeper into them.

Read more »

A businessman compares the growth trajectory of property versus shares.
Growth Shares

2 ASX giants to buy for decades of growth and dividends

Income or growth? Why not have both!

Read more »

A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.
Growth Shares

3 Australian shares to buy and hold for 20 more years

Let's see why these shares could be among the best to buy and hold until the 2040s.

Read more »